Ledger.Open graph →

SEC Form D · filed July 16, 2024

Avicenna Biosciences, Inc

Offering

$6.0M

Sold

$6.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

DURHAM, NC

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

John Hamer · Durham, NCDirector Thomas Kaiser · Durham, NCExec · Director Dennis Langer · Durham, NCDirector Pieter Burger · Durham, NCExec · Director Christopher Meldrum · Durham, NCExec · Director Michael A. Harstrick · Hingham, MAExec · Director Andrew Durgee · New York, NYExec · Director Neil Cohen · Denver, CODirector Jonathan A. Bronson · Hingham, MAExec · Director Joshua Gruenstein · Watertown, MADirector Greg Lyons · Dallas, TXExec · Director Tim Woodward · San Francisco, CAExec · Director Kenneth Hood · San Diego, CAExec · Director Fred H. Jeffery · Safety Harbor, FLDirector Lorraine J. Hall · Matthews, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗